Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadership Ashley KalinauskasApril 25, 2023
Torigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement Ashley KalinauskasApril 13, 2023
Torigen Pharmaceuticals and VerticalVet Enter into Preferred Partnership Ashley KalinauskasDecember 8, 2022
Three Notre Dame alumni who are changing the world - powered by ESTEEM Ashley KalinauskasDecember 4, 2022
Torigen Pharmaceuticals Announces Completion of $13 Million Capital Raise Ashley KalinauskasNovember 17, 2022Torigen
Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health Ashley KalinauskasJuly 5, 2022
Torigen Expands Histopathology Services Through Strategic Partnership with Vidium Animal Health Ashley KalinauskasApril 27, 2022
Pet cancer vaccine maker Torigen Pharmaceuticals expanding with new lease, venture funding Ashley KalinauskasFebruary 2, 2022
Torigen Appoints Veterinary Oncologist, Dr. Chelsea Greenberg, as Vice President of Clinical Affairs Ashley KalinauskasOctober 15, 2021
Field safety experience with an autologous cancer vaccine in tumor-bearing cats: a retrospective study of 117 cases (2015–2020) Ashley KalinauskasAugust 6, 2021
Torigen Wins Big at Yale Innovation Summit and Animal Health Innovation Showcase Ashley KalinauskasJuly 9, 2021
Following $3.5M fundraise, Farmington's Torigen Pharmaceuticals signs distribution deal with Victor Medical Group Ashley KalinauskasJune 11, 2021
Torigen Pharmaceuticals Signs First Distribution Agreement with Victor Medical Company Ashley KalinauskasJune 9, 2021
Torigen Announces Positive Results for Dogs Administered the Company’s Autologous Cancer Vaccine Ashley KalinauskasDecember 3, 2020
